Absci Corp(us:ABSI)

    2.91

    -2.68%

    Updated on 2024-12-23

    Open:2.99
    Close:2.91
    High:2.99
    Low:2.87
    Pre Close:2.99
    Volume:1.09M
    Amount:3.18M
    Turnover:0.95%
    Shares:114.86M
    MarketCap:334.23M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3011990.00%000
    2024-03-311186046161253.51%522920
    2023-12-31803371378536.22%202127
    2023-09-30773379196036.36%91733
    2023-06-30923411411036.84%182141
    2023-03-31844035402843.63%92232
    2022-12-31914181159545.25%162531
    2022-09-30854396522147.33%132227
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Fmr Llc1481045413.11%9489336.85%
    2024-03-31Redmile Group, Llc82533167.30%2222222.77%
    2024-03-31Fred Alger Management, Llc74078096.56%7407809
    2024-03-31Vanguard Group Inc34452723.05%86913133.74%
    2024-03-31Ark Investment Management Llc32770942.90%3277094
    2024-03-31Millennium Management Llc17699941.57%1242254235.39%
    2024-03-31Marshall Wace, Llp14868231.32%1252881535.55%
    2024-03-31Woodline Partners Lp14741851.30%1474185
    2024-03-31Laurion Capital Management Lp11864271.05%1072573942.06%
    2024-03-31Affinity Asset Advisors, Llc10250000.91%1025000

    About

    Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
    Address:18105 SE Mill Plain Boulevard

    Market Movers